NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $839,836 | +12.4% | 8,245 | +11.4% | 0.02% | +13.3% |
| Q2 2023 | $747,037 | +6.8% | 7,403 | -2.7% | 0.02% | 0.0% |
| Q1 2023 | $699,660 | +3.8% | 7,605 | +2.4% | 0.02% | -6.2% |
| Q4 2022 | $674,038 | +19.1% | 7,430 | -0.2% | 0.02% | +45.5% |
| Q3 2022 | $566,000 | -8.6% | 7,446 | +1.7% | 0.01% | -8.3% |
| Q2 2022 | $619,000 | -5.1% | 7,319 | -1.5% | 0.01% | +9.1% |
| Q1 2022 | $652,000 | +0.3% | 7,427 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $650,000 | +0.5% | 7,427 | -6.2% | 0.01% | -8.3% |
| Q3 2021 | $647,000 | -14.0% | 7,916 | -4.0% | 0.01% | -14.3% |
| Q2 2021 | $752,000 | +8.8% | 8,244 | +2.0% | 0.01% | +7.7% |
| Q1 2021 | $691,000 | -2.0% | 8,086 | +8.2% | 0.01% | -7.1% |
| Q4 2020 | $705,000 | +150.0% | 7,471 | +130.7% | 0.01% | +133.3% |
| Q3 2020 | $282,000 | -20.8% | 3,239 | -20.6% | 0.01% | -25.0% |
| Q2 2020 | $356,000 | – | 4,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |